Zineb Ghrieb

Paris, 75010, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Chronology of the ISO 9001:2015 certification and satisfaction survey in the multidisciplinary Clinical Investigation Center (CIC) of the historic Saint-Louis Hospital during the COVID-19 pandemic

Chronology of the ISO 9001:2015 certification and satisfaction survey in the multidisciplinary Clinical Investigation Center (CIC) of the historic Saint-Louis Hospital during the COVID-19 pandemic

Journal: Therapie

Published: May 02, 2023

Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study.

Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study.

Journal: ESMO open

Published: December 09, 2022

Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.

Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 07, 2022

Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses' infections.

Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses' infections.

Journal: Therapie

Published: April 27, 2022

Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study.

Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study.

Journal: ESMO open

Published: November 01, 2021

An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown

An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown

Journal: Therapie

Published: November 13, 2020

Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAF V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism.

Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAF V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 30, 2020

A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans.

A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans.

Journal: The Journal of investigative dermatology

Published: February 26, 2020

Satisfaction survey in the clinical investigations center (CIC-1427) in Saint-Louis hospital Paris, France

Satisfaction survey in the clinical investigations center (CIC-1427) in Saint-Louis hospital Paris, France

Journal: Therapie

Published: June 28, 2019

A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors.

A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 16, 2019

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo.

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo.

Journal: Blood cancer journal

Published: August 14, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026